220 related articles for article (PubMed ID: 15955122)
1. Topiramate ameliorates hyperglycaemia and improves glucose-stimulated insulin release in ZDF rats and db/db mice.
Liang Y; Chen X; Osborne M; DeCarlo SO; Jetton TL; Demarest K
Diabetes Obes Metab; 2005 Jul; 7(4):360-9. PubMed ID: 15955122
[TBL] [Abstract][Full Text] [Related]
2. The messenger RNA profiles in liver, hypothalamus, white adipose tissue, and skeletal muscle of female Zucker diabetic fatty rats after topiramate treatment.
Liang Y; She P; Wang X; Demarest K
Metabolism; 2006 Oct; 55(10):1411-9. PubMed ID: 16979414
[TBL] [Abstract][Full Text] [Related]
3. Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats.
Wilkes JJ; Nelson E; Osborne M; Demarest KT; Olefsky JM
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E617-24. PubMed ID: 15536205
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice.
Yamanaka M; Itakura Y; Inoue T; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
Metabolism; 2006 Oct; 55(10):1286-92. PubMed ID: 16979397
[TBL] [Abstract][Full Text] [Related]
5. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA
Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870
[TBL] [Abstract][Full Text] [Related]
7. Topiramate reduces energy and fat gains in lean (Fa/?) and obese (fa/fa) Zucker rats.
Picard F; Deshaies Y; Lalonde J; Samson P; Richard D
Obes Res; 2000 Dec; 8(9):656-63. PubMed ID: 11225714
[TBL] [Abstract][Full Text] [Related]
8. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
9. Recurrent intermittent restraint delays fed and fasting hyperglycemia and improves glucose return to baseline levels during glucose tolerance tests in the Zucker diabetic fatty rat--role of food intake and corticosterone.
Bates HE; Kiraly MA; Yue JT; Goche Montes D; Elliott ME; Riddell MC; Matthews SG; Vranic M
Metabolism; 2007 Aug; 56(8):1065-75. PubMed ID: 17618951
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism.
Bergeron R; Yao J; Woods JW; Zycband EI; Liu C; Li Z; Adams A; Berger JP; Zhang BB; Moller DE; Doebber TW
Endocrinology; 2006 Sep; 147(9):4252-62. PubMed ID: 16728496
[TBL] [Abstract][Full Text] [Related]
11. Intermittent administration of brain-derived neurotrophic factor (BDNF) ameliorates glucose metabolism and prevents pancreatic exhaustion in diabetic mice.
Yamanaka M; Itakura Y; Ono-Kishino M; Tsuchida A; Nakagawa T; Taiji M
J Biosci Bioeng; 2008 Apr; 105(4):395-402. PubMed ID: 18499057
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in Zucker diabetic fatty rats.
van Poelje PD; Potter SC; Chandramouli VC; Landau BR; Dang Q; Erion MD
Diabetes; 2006 Jun; 55(6):1747-54. PubMed ID: 16731838
[TBL] [Abstract][Full Text] [Related]
13. The development of overt diabetes in young Zucker Diabetic Fatty (ZDF) rats and the effects of chronic MCC-555 treatment.
Pickavance L; Widdowson PS; King P; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Oct; 125(4):767-70. PubMed ID: 9831913
[TBL] [Abstract][Full Text] [Related]
14. Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095.
Arakawa K; Ishihara T; Oku A; Nawano M; Ueta K; Kitamura K; Matsumoto M; Saito A
Br J Pharmacol; 2001 Jan; 132(2):578-86. PubMed ID: 11159708
[TBL] [Abstract][Full Text] [Related]
15. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice.
Wang Q; Brubaker PL
Diabetologia; 2002 Sep; 45(9):1263-73. PubMed ID: 12242459
[TBL] [Abstract][Full Text] [Related]
17. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
Wasan KM; Risovic V; Yuen VG; McNeill JH
J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
[TBL] [Abstract][Full Text] [Related]
18. The effects of topiramate and sex hormones on energy balance of male and female rats.
Richard D; Picard F; Lemieux C; Lalonde J; Samson P; Deshaies Y
Int J Obes Relat Metab Disord; 2002 Mar; 26(3):344-53. PubMed ID: 11896489
[TBL] [Abstract][Full Text] [Related]
19. Hydrangea dulcis folium preserves beta-cell mass in diabetic db/db mice.
Kim MJ; Leem KH; Kim HK
Food Chem Toxicol; 2009 Jul; 47(7):1685-8. PubMed ID: 19394398
[TBL] [Abstract][Full Text] [Related]
20. Topiramate treatment causes skeletal muscle insulin sensitization and increased Acrp30 secretion in high-fat-fed male Wistar rats.
Wilkes JJ; Nguyen MT; Bandyopadhyay GK; Nelson E; Olefsky JM
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1015-22. PubMed ID: 16030065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
